Filing Flows › HealthLynked (HLYK) › Q2 2026 › vs Q2 2025
HealthLynked (HLYK) Q2 2026 vs Q2 2025 (year over year)
HealthLynked's revenue fell $343K (-58%) from $592K in Q2 2025 to $250K in Q2 2026. The biggest changes: Patient service revenue, net −$342K (-60%); Product revenue −$293 (-2%); Subscription revenue +$88 (+1%).
HealthLynked, Q2 2026: revenue $250K (-58% year over year), operating margin -215.7%, net loss $820K, operating cash flow −$350K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Patient service revenue, net | $231K | $573K | −$342K | -60% |
| Product revenue | $12K | $12K | −$293 | -2% |
| Subscription revenue | $7K | $7K | $88 | +1% |
| Revenue | $250K | $592K | −$343K | -58% |
| Net loss | $820K | $701K | $119K | +17% |
| Costs & expenses | $1.1M | $1.3M | −$224K | -17% |
| Operating costs | $789K | $1.0M | −$239K | -23% |
| Interest & other, net | $281K | $266K | $15K | +6% |
| SG&A | $517K | $452K | $66K | +15% |
| Other operating costs | $271K | $576K | −$305K | -53% |
| Operating cash sources | $820K | $701K | $119K | +17% |
| Depreciation | $10K | $27K | −$17K | -62% |
| Share-based compensation | $88K | $5K | $83K | 17× |
| Working capital & other | $371K | $251K | $120K | +48% |
| Cash used in operations | $350K | $418K | −$67K | -16% |
| Net loss absorbed | $820K | $701K | $119K | +17% |
Questions
How much did HealthLynked's revenue grow year over year in Q2 2026?
HealthLynked's revenue fell $343K (-58%) from $592K in Q2 2025 to $250K in Q2 2026.
What drove HealthLynked's revenue change in Q2 2026?
Patient service revenue, net −$342K (-60%); Product revenue −$293 (-2%); Subscription revenue +$88 (+1%).